| For: | Li YY, Ge QX, Cao J, Zhou YJ, Du YL, Shen B, Wan YJY, Nie YQ. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients. World J Gastroenterol 2016; 22(11): 3227-3233 [PMID: 27004000 DOI: 10.3748/wjg.v22.i11.3227] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i11/3227.htm |
| Number | Citing Articles |
| 1 |
Minoru Koi, Yoshiki Okita, John M. Carethers. <i>Fusobacterium nucleatum</i> Infection in Colorectal Cancer: Linking Inflammation, DNA Mismatch Repair and Genetic and Epigenetic Alterations. Journal of the Anus, Rectum and Colon 2018; 2(2) doi: 10.23922/jarc.2017-055
|
| 2 |
Nasser Hashemi Goradel, Siamak Heidarzadeh, Samira Jahangiri, Bagher Farhood, Keywan Mortezaee, Neda Khanlarkhani, Babak Negahdari. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview. Journal of Cellular Physiology 2019; 234(3) doi: 10.1002/jcp.27250
|
| 3 |
Marco Vacante, Roberto Ciuni, Francesco Basile, Antonio Biondi. Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence. Biomedicines 2020; 8(11) doi: 10.3390/biomedicines8110489
|
| 4 |
Hiroyuki Yamamoto, Kohzoh Imai. An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine. Seminars in Oncology 2019; 46(3) doi: 10.1053/j.seminoncol.2019.08.003
|
| 5 |
Biying Chen, Guangye Du, Jiahui Guo, Yanjie Zhang. Bugs, drugs, and cancer: can the microbiome be a potential therapeutic target for cancer management?. Drug Discovery Today 2019; 24(4) doi: 10.1016/j.drudis.2019.02.009
|
| 6 |
Wenhua Shao, Natsumi Fujiwara, Yasuhiro Mouri, Satoru Kisoda, Kayo Yoshida, Kaya Yoshida, Hiromichi Yumoto, Kazumi Ozaki, Naozumi Ishimaru, Yasusei Kudo. Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-94384-1
|
| 7 |
Inés Mármol, Cristina Sánchez-de-Diego, Alberto Pradilla Dieste, Elena Cerrada, María Rodriguez Yoldi. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. International Journal of Molecular Sciences 2017; 18(1) doi: 10.3390/ijms18010197
|
| 8 |
Shujie Chen, Tingting Su, Ying Zhang, Allen Lee, Jiamin He, Qiwei Ge, Lan Wang, Jianmin Si, Wei Zhuo, Liangjing Wang. Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7. Gut Microbes 2020; 11(3) doi: 10.1080/19490976.2019.1695494
|
| 9 |
Junchuan Li, Yuzhou Zhu, Lie Yang, Ziqiang Wang. Effect of gut microbiota in the colorectal cancer and potential target therapy. Discover Oncology 2022; 13(1) doi: 10.1007/s12672-022-00517-x
|
| 10 |
João Felipe Mota, Jens Walter, Carla M. Prado. Insights Into the Relationship Between Gut Microbiota and Colorectal Cancer. Current Colorectal Cancer Reports 2018; 14(6) doi: 10.1007/s11888-018-0419-4
|
| 11 |
Eiman A. Alhinai, Gemma E. Walton, Daniel M. Commane. The Role of the Gut Microbiota in Colorectal Cancer Causation. International Journal of Molecular Sciences 2019; 20(21) doi: 10.3390/ijms20215295
|
| 12 |
Gulmira Kulmambetova, Botakoz Kurentay, Alua Gusmaulemova, Dina Bayanbek, Meiram Mamlin, Saule Khamzina, Sanzhar Shalekenov, Arman Kozhakhmetov. Investigation of the relationship between Fusobacterium nucleatum presence and inflammatory mediator expression in Kazakhstani patients with colorectal cancer. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1699745
|
| 13 |
Rafael Garcia-Carretero, Marta Lopez-Lomba, Blanca Carrasco-Fernandez, Maria Teresa Duran-Valle. Clinical Features and Outcomes of Fusobacterium Species Infections in a Ten-Year Follow-up. The Journal of Critical Care Medicine 2017; 3(4) doi: 10.1515/jccm-2017-0029
|
| 14 |
Robert G. Mothersole, Cory R. Billett, Gurpreet Saini, Mina K. Mothersole, Amanda L. Darbyshire, Kirsten R. Wolthers. S224 Presents a Catalytic Trade-off in PLP-Dependent l-Lanthionine Synthase from Fusobacterium nucleatum. Biochemistry 2020; 59(44) doi: 10.1021/acs.biochem.0c00683
|
| 15 |
Giovambattista Pani. Fusobacterium & Co. at the Stem of Cancer: Microbe–Cancer Stem Cell Interactions in Colorectal Carcinogenesis. Cancers 2023; 15(9) doi: 10.3390/cancers15092583
|
| 16 |
Sally Temraz, Farah Nassar, Rihab Nasr, Maya Charafeddine, Deborah Mukherji, Ali Shamseddine. Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer. International Journal of Molecular Sciences 2019; 20(17) doi: 10.3390/ijms20174155
|
| 17 |
Dan Long, Chenhan Mao, Zhensheng Zhang, Junjun Zou, Ying Zhu. Visual analysis of colorectal cancer and gut microbiota: A bibliometric analysis from 2002 to 2022. Medicine 2023; 102(44) doi: 10.1097/MD.0000000000035727
|
| 18 |
Lu Zhang, Xiao-Xu Leng, Jianxun Qi, Ni Wang, Ji-Xuan Han, Zhi-Hang Tao, Zi-Yan Zhuang, Yimeng Ren, Yi-Le Xie, Shan-Shan Jiang, Jia-Lu Li, Huimin Chen, Cheng-Bei Zhou, Yun Cui, Xiaoyu Chen, Zheng Wang, Zi-Zhen Zhang, Jie Hong, Hao-Yan Chen, Weihong Jiang, Ying-Xuan Chen, Xin Zhao, Jun Yu, Jing-Yuan Fang. The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis. Nature Microbiology 2024; 9(9) doi: 10.1038/s41564-024-01784-w
|
| 19 |
Harrisham Kaur, Chandrani Das, Sharmila S. Mande. In Silico Analysis of Putrefaction Pathways in Bacteria and Its Implication in Colorectal Cancer. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.02166
|
| 20 |
Jiali Zhang, Ji Tao, Ruo-Nan Gao, Zhi-Yuan Wei, Yu-Shan He, Chun-Yan Ren, Qi-Chun Li, Yan-Shan Liu, Ke-Wei Wang, Gong Yang, Chengjia Qian, Jian-Huan Chen. Cytotoxic T-Cell Trafficking Chemokine Profiles Correlate With Defined Mucosal Microbial Communities in Colorectal Cancer. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.715559
|
| 21 |
Songlin Ran, Jinhua Ye, Hufei Wang, Fangzhou Liu, Suwen Ou, Zhiyong Chen, Yanni Song, Shu-lin Liu, Rui Huang. Single-cell and bulk transcriptomics reveal Fusobacterium nucleatum promotes colorectal cancer metastasis by upregulating LAMC2 in in vitro and in vivo models. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-26249-w
|
| 22 |
Joana Sorino, Mario Della Mura, Giuseppe Ingravallo, Gerardo Cazzato, Cristina Pizzimenti, Valeria Zuccalà, Ludovica Pepe, Emanuela Germanà, Maurizio Martini, Antonio Ieni, Vincenzo Fiorentino. Fusobacterium nucleatum and Gastric Cancer: An Emerging Connection. International Journal of Molecular Sciences 2025; 26(16) doi: 10.3390/ijms26167915
|
| 23 |
Konstantinos Kossenas, Constantina Constantinou. Epidemiology, Molecular Mechanisms, and Clinical Trials: an Update on Research on the Association Between Red Meat Consumption and Colorectal Cancer. Current Nutrition Reports 2021; 10(4) doi: 10.1007/s13668-021-00377-x
|
| 24 |
Suwen Ou, Haipeng Chen, Hufei Wang, Jinhua Ye, Huidi Liu, Yangbao Tao, Songlin Ran, Xiaoqin Mu, Fangzhou Liu, Shuang Zhu, Kangjia Luo, Zilong Guan, Yinghu Jin, Rui Huang, Yanni Song, Shu-lin Liu. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04527-3
|
| 25 |
Shuji Ogino, Jonathan A. Nowak, Tsuyoshi Hamada, Danny A. Milner, Reiko Nishihara. Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology. Annual Review of Pathology: Mechanisms of Disease 2019; 14(1) doi: 10.1146/annurev-pathmechdis-012418-012818
|
| 26 |
D. I. Trukhan. Oral microbiota and gastroenterological diseases: a hypothetical “journey” of the periodontal microbiota on the “periodontal-gastroenterological express” along the route mouth-intestine. Experimental and Clinical Gastroenterology 2026; (7) doi: 10.31146/1682-8658-ecg-239-7-12-20
|
| 27 |
Stephen H. Kasper, Carolina Morell-Perez, Thomas P. Wyche, Theodore R. Sana, Linda A. Lieberman, Erik C. Hett. Colorectal cancer-associated anaerobic bacteria proliferate in tumor spheroids and alter the microenvironment. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-62139-z
|
| 28 |
Anirudh P. Shanbhag. The Gut Microbiome in Precision Medicine. 2026; doi: 10.1016/B978-0-443-40483-2.00040-6
|
| 29 |
Marco Antonio Hernández-Luna, Sergio López-Briones, Rosendo Luria-Pérez. The Four Horsemen in Colon Cancer. Journal of Oncology 2019; 2019 doi: 10.1155/2019/5636272
|
| 30 |
Mingyang Song, Andrew T. Chan, Jun Sun. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. Gastroenterology 2020; 158(2) doi: 10.1053/j.gastro.2019.06.048
|
| 31 |
José G. Datorre, Mariana B. dos Reis, Ana C. de Carvalho, Jun Porto, Gabriela H. Rodrigues, Adhara B. Lima, Monise T. Reis, Welinton Hirai, Claudio L. Hashimoto, Denise P. Guimarães, Rui M. Reis. Enhancing Colorectal Cancer Screening with Droplet Digital PCR Analysis of Fusobacterium nucleatum in Fecal Immunochemical Test Samples. Cancer Prevention Research 2024; 17(10) doi: 10.1158/1940-6207.CAPR-23-0331
|
| 32 |
Martina King, Hermione Hurley, Kevin R. Davidson, Edward C. Dempsey, Michelle A. Barron, Edward D. Chan, Amy Frey. The Link between Fusobacteria and Colon Cancer: a Fulminant Example and Review of the Evidence. Immune Network 2020; 20(4) doi: 10.4110/in.2020.20.e30
|
| 33 |
Yuko Yamaoka, Yutaka Suehiro, Shinichi Hashimoto, Tomomi Hoshida, Michiyo Fujimoto, Michiya Watanabe, Daiki Imanaga, Kouhei Sakai, Toshihiko Matsumoto, Mitsuaki Nishioka, Taro Takami, Nobuaki Suzuki, Shoichi Hazama, Hiroaki Nagano, Isao Sakaida, Takahiro Yamasaki.
Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population. Journal of Gastroenterology 2018; 53(4) doi: 10.1007/s00535-017-1382-6
|
| 34 |
Roghayeh Nouri, Alka Hasani, Kourosh Masnadi Shirazi, Mohammad Reza Alivand, Bita Sepehri, Simin Sotoodeh, Fatemeh Hemmati, Mohammad Ahangarzadeh Rezaee. Escherichia coli and Colorectal Cancer: Unfolding the Enigmatic
Relationship. Current Pharmaceutical Biotechnology 2022; 23(10) doi: 10.2174/1389201022666210910094827
|
| 35 |
Long-Chen Yu, Ya-Ping Li, Yue-Ming Xin, Mai Mao, Ya-Xin Pan, Yi-Xuan Qu, Zheng-Dong Luo, Yi Zhang, Xin Zhang. Application of <i>Fusobacterium nucleatum</i> as a biomarker in gastrointestinal malignancies. World Journal of Gastrointestinal Oncology 2024; 16(6): 2271-2283 doi: 10.4251/wjgo.v16.i6.2271
|
| 36 |
Yung-Yu Hsieh, Shui-Yi Tung, Hung-Yu Pan, Chih-Wei Yen, Huang-Wei Xu, Ying-Jhen Lin, Yi-Fang Deng, Wan-Ting Hsu, Cheng-Shyong Wu, Chin Li. Increased Abundance of Clostridium and Fusobacterium in Gastric Microbiota of Patients with Gastric Cancer in Taiwan. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-017-18596-0
|
| 37 |
Mark Stasiewicz, Tomasz M. Karpiński. The oral microbiota and its role in carcinogenesis. Seminars in Cancer Biology 2022; 86 doi: 10.1016/j.semcancer.2021.11.002
|
| 38 |
Rongrong Li, Jilu Shen, Yuanhong Xu. Fusobacterium nucleatum and Colorectal Cancer. Infection and Drug Resistance 2022; doi: 10.2147/IDR.S357922
|
| 39 |
Wen-dan Chen, Xin Zhang, Ya-ping Zhang, Cong-bo Yue, Yan-lei Wang, Hong-wei Pan, Yan-li Zhang, Hui Liu, Yi Zhang. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer. Current Medical Science 2022; 42(3) doi: 10.1007/s11596-022-2597-1
|
| 40 |
Asma Rafique, Young-Sang Koh.
Association of Fusobacterium nucleatum in the Progression of Colorectal Cancer
. Journal of Bacteriology and Virology 2021; 51(2) doi: 10.4167/jbv.2021.51.2.039
|
| 41 |
Pin Guo, Zibin Tian, Xinjuan Kong, Lin Yang, Xinzhi Shan, Bingzi Dong, Xueli Ding, Xue Jing, Chen Jiang, Na Jiang, Yanan Yu. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01677-w
|
| 42 |
Maryam Ranjbar, Rasoul Salehi, Shaghayegh Haghjooy Javanmard, Laleh Rafiee, Habibollah Faraji, Sima jafarpor, Gordon A. Ferns, Majid Ghayour-Mobarhan, Mostafa Manian, Reza Nedaeinia. The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01886-z
|
| 43 |
Jie Zhang, Zhao-Jun Wei, Guangsen Fan. Emerging Understanding of Gut Microbiome in Colorectal Cancer and Food-Related Intervention Strategies. Foods 2025; 14(17) doi: 10.3390/foods14173040
|
| 44 |
Kumar Ganesan, Songhe Guo, Sundaz Fayyaz, Ge Zhang, Baojun Xu. Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy. Cancers 2019; 11(10) doi: 10.3390/cancers11101592
|
| 45 |
Siti Maryam Ahmad Kendong, Raja Affendi Raja Ali, Khairul Najmi Muhammad Nawawi, Hajar Fauzan Ahmad, Norfilza Mohd Mokhtar. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.744606
|
| 46 |
Shujiro Okuda, Yoshifumi Shimada, Yosuke Tajima, Kizuki Yuza, Yuki Hirose, Hiroshi Ichikawa, Masayuki Nagahashi, Jun Sakata, Yiwei Ling, Nobuaki Miura, Mika Sugai, Yu Watanabe, Shiho Takeuchi, Toshifumi Wakai. Profiling of host genetic alterations and intra-tumor microbiomes in colorectal cancer. Computational and Structural Biotechnology Journal 2021; 19 doi: 10.1016/j.csbj.2021.05.049
|
| 47 |
Fu-Mei Shang, Hong-Li Liu. <i>Fusobacterium nucleatum</i> and colorectal cancer: A review. World Journal of Gastrointestinal Oncology 2018; 10(3): 71-81 doi: 10.4251/wjgo.v10.i3.71
|
| 48 |
. 2018; doi: 10.70675/8c2a9041zc9bcz4cabzbe6cz5b5453a81fa4
|
| 49 |
Susan Bullman, Chandra S. Pedamallu, Ewa Sicinska, Thomas E. Clancy, Xiaoyang Zhang, Diana Cai, Donna Neuberg, Katherine Huang, Fatima Guevara, Timothy Nelson, Otari Chipashvili, Timothy Hagan, Mark Walker, Aruna Ramachandran, Begoña Diosdado, Garazi Serna, Nuria Mulet, Stefania Landolfi, Santiago Ramon y Cajal, Roberta Fasani, Andrew J. Aguirre, Kimmie Ng, Elena Élez, Shuji Ogino, Josep Tabernero, Charles S. Fuchs, William C. Hahn, Paolo Nuciforo, Matthew Meyerson.
Analysis of
Fusobacterium
persistence and antibiotic response in colorectal cancer
. Science 2017; 358(6369) doi: 10.1126/science.aal5240
|
| 50 |
Hongyu Liu, Yunjian Yu, Alideertu Dong, Mahmoud Elsabahy, Ying‐Wei Yang, Hui Gao. Emerging strategies for combating Fusobacterium nucleatum in colorectal cancer treatment: Systematic review, improvements and future challenges. Exploration 2024; 4(1) doi: 10.1002/EXP.20230092
|
| 51 |
Na Wu, Yu-Qing Feng, Na Lyu, Di Wang, Wei-Dong Yu, Yong-Fei Hu. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model. World Journal of Gastroenterology 2022; 28(18): 1981-1995 doi: 10.3748/wjg.v28.i18.1981
|
| 52 |
Joel Faintuch, Jacob J. Faintuch. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. 2019; doi: 10.1016/B978-0-12-815249-2.00046-4
|
| 53 |
Shuang Wang, Yang Liu, Jun Li, Lei Zhao, Wei Yan, Baiqiang Lin, Xiao Guo, Yunwei Wei. Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.710165
|
| 54 |
Nicholas R. Suss, Bidisha Barat, Mohsen Rouhani Ravari, Benjamin D. Shogan. The impact of the microbiome on colorectal cancer recurrence after resection. Journal of Gastrointestinal Surgery 2026; 30(7) doi: 10.1016/j.gassur.2026.102360
|
| 55 |
Shiwang Wu, Xinyi Ye, Jingsi Wang, Mei Li, Yage Fu, Shan Wang. Microbial crosstalk along the oral–gut axis: organ-specific oncogenic adaptations of Porphyromonas gingivalis and Fusobacterium nucleatum. Neoplasia 2026; 74 doi: 10.1016/j.neo.2026.101290
|
| 56 |
L. A. Tashireva, V. M. Perelmuter, V. N. Manskikh, E. V. Denisov, O. E. Savelieva, E. V. Kaygorodova, M. V. Zavyalova. Types of immune-inflammatory responses as a reflection of cell–cell interactions under conditions of tissue regeneration and tumor growth. Biochemistry (Moscow) 2017; 82(5) doi: 10.1134/S0006297917050029
|
| 57 |
Reza Torkashvand, Bahareh Hajikhani, Masoud Dadashi, Hossein Dabiri, Reza Hosseini Doust. The Correlation Between Fusobacterium nucleatum and Colorectal Cancer: A Comprehensive Review. International Journal of Enteric Pathogens 2024; 12(3) doi: 10.34172/ijep.5672
|
| 58 |
Yang Liu, Yoshifumi Baba, Takatsugu Ishimoto, Masaaki Iwatsuki, Yukiharu Hiyoshi, Yuji Miyamoto, Naoya Yoshida, Rong Wu, Hideo Baba. Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer. Journal of Gastroenterology 2019; 54(1) doi: 10.1007/s00535-018-1512-9
|
| 59 |
Kangjia Luo, Yvkun Zhang, Chao Xv, Jingjing Ji, Ge Lou, Xiaorong Guo, Meilun Chen, Yingjie Zhang, Huiying Wei, Mian Guo, Rui Huang, Shan Yu. Fusobacterium nucleatum, the communication with colorectal cancer. Biomedicine & Pharmacotherapy 2019; 116 doi: 10.1016/j.biopha.2019.108988
|
| 60 |
Julia L. Drewes, Jada C. Domingue, Franck Housseau. Colorectal Neoplasia and the Colorectal Microbiome. 2020; doi: 10.1016/B978-0-12-819672-4.00008-8
|
| 61 |
Xin He, Qing Zhao, Jianhong Zhang, Jing Shi, Ningyi Wan, Bin Tang, Bo Tian, Pu Li. Potential and application of Fusobacterium nucleatum in the diagnosis and treatment of colorectal cancer. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1652702
|
| 62 |
Shailesh M. Advani, Pragati Advani, Stacia M. DeSantis, Derek Brown, Helena M. VonVille, Michael Lam, Jonathan M. Loree, Amir Mehrvarz Sarshekeh, Jan Bressler, David S. Lopez, Carrie R. Daniel, Michael D. Swartz, Scott Kopetz. Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis. Translational Oncology 2018; 11(5) doi: 10.1016/j.tranon.2018.07.008
|
| 63 |
Miriam López-Gómez, Belén García de Santiago, Pedro-David Delgado-López, Eduardo Malmierca, Jesús González-Olmedo, César Gómez-Raposo, Carmen Sandoval, Pilar Ruiz-Seco, Nora Escribano, Jorge Francisco Gómez-Cerezo, Enrique Casado. Gastrointestinal tumors and infectious agents: A wide field to explore. World Journal of Meta-Analysis 2021; 9(6): 505-521 doi: 10.13105/wjma.v9.i6.505
|
| 64 |
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Pragya Bradu, Reshma Murali, Sandra Kannampuzha, Tamizhini Loganathan, George Priya Doss C, Arun Prakash B.P, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Abilash Valsala Gopalakrishnan. The crosstalk of the human microbiome in breast and colon cancer: A metabolomics analysis. Critical Reviews in Oncology/Hematology 2022; 176 doi: 10.1016/j.critrevonc.2022.103757
|
| 65 |
John Repass, Elizabeth Iorns, Alexandria Denis, Stephen R Williams, Nicole Perfito, Timothy M Errington. Replication Study: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. eLife 2018; 7 doi: 10.7554/eLife.25801
|
| 66 |
Francesca Benedetti, Fiorenza Cocchi, Olga S. Latinovic, Sabrina Curreli, Selvi Krishnan, Arshi Munawwar, Robert C. Gallo, Davide Zella. Role of Mycoplasma Chaperone DnaK in Cellular Transformation. International Journal of Molecular Sciences 2020; 21(4) doi: 10.3390/ijms21041311
|
| 67 |
Kosuke Mima, Yin Cao, Andrew T Chan, Zhi Rong Qian, Jonathan A Nowak, Yohei Masugi, Yan Shi, Mingyang Song, Annacarolina da Silva, Mancang Gu, Wanwan Li, Tsuyoshi Hamada, Keisuke Kosumi, Akiko Hanyuda, Li Liu, Aleksandar D Kostic, Marios Giannakis, Susan Bullman, Caitlin A Brennan, Danny A Milner, Hideo Baba, Levi A Garraway, Jeffrey A Meyerhardt, Wendy S Garrett, Curtis Huttenhower, Matthew Meyerson, Edward L Giovannucci, Charles S Fuchs, Reiko Nishihara, Shuji Ogino. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clinical and Translational Gastroenterology 2016; 7(11) doi: 10.1038/ctg.2016.53
|
| 68 |
Dervla Kelly, Liying Yang, Zhiheng Pei. Gut Microbiota, Fusobacteria, and Colorectal Cancer. Diseases 2018; 6(4) doi: 10.3390/diseases6040109
|
| 69 |
Xinran Zhang, Yixin Chen, Yuwei Xia, Shenghao Lin, Xinlei Zhou, Xi Pang, Jieru Yu, Leitao Sun. Oral microbiota in colorectal cancer: Unraveling mechanisms and application potential. Life Sciences 2025; 365 doi: 10.1016/j.lfs.2025.123462
|
| 70 |
Ying Li, Zheming Guo, Haipeng Cui, Tu Wang, Yuhang Xu, Juan Zhao. Urantide prevents CCl4‑induced acute liver injury in rats by regulating the MAPK signalling pathway. Molecular Medicine Reports 2021; 24(4) doi: 10.3892/mmr.2021.12329
|
| 71 |
Christian Gethings-Behncke, Helen G. Coleman, Haydee W.T. Jordao, Daniel B. Longley, Nyree Crawford, Liam J. Murray, Andrew T. Kunzmann.
Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis. Cancer Epidemiology, Biomarkers & Prevention 2020; 29(3) doi: 10.1158/1055-9965.EPI-18-1295
|
| 72 |
Vytenis Petkevicius, Konrad Lehr, Juozas Kupcinskas, Alexander Link. <i>Fusobacterium nucleatum</i>: Unraveling its potential role in gastric carcinogenesis. World Journal of Gastroenterology 2024; 30(35): 3972-3984 doi: 10.3748/wjg.v30.i35.3972
|
| 73 |
Caitlin A. Brennan, Wendy S. Garrett. Fusobacterium nucleatum — symbiont, opportunist and oncobacterium. Nature Reviews Microbiology 2019; 17(3) doi: 10.1038/s41579-018-0129-6
|
| 74 |
Yinghui Zhao, Chuanxin Wang, Ajay Goel. Role of gut microbiota in epigenetic regulation of colorectal Cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1875(1) doi: 10.1016/j.bbcan.2020.188490
|
| 75 |
Kaitlyn D. LaCourse, Martha Zepeda-Rivera, Andrew G. Kempchinsky, Alexander Baryiames, Samuel S. Minot, Christopher D. Johnston, Susan Bullman. The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota. Cell Reports 2022; 41(7) doi: 10.1016/j.celrep.2022.111625
|
| 76 |
Kate L. F. Johnstone, Sinead Toomey, Stephen Madden, Brian D. P. O’Neill, Bryan T Hennessy. Fusobacterium nucleatum: caution with interpreting historical patient sample cohort. Journal of Pathology and Translational Medicine 2021; 55(6) doi: 10.4132/jptm.2021.08.27
|
| 77 |
Devaraja Gayathri, Chakra Siddappa Prashantkumar, Mahanthesh Vasudha. Microbiome-Gut-Brain Axis. 2022; doi: 10.1007/978-981-16-1626-6_2
|
| 78 |
Guodong Liu, Baowei Wang, Yanping Huang, Kailing Li, Wenhua Ge, Mingai Zhang, Bin Yue, Min Kong. The Growth Rate, Immune Status, Duodenal Development, and Cecal Microbial Diversity of 24-Day-Old Offspring of SD Rats Received Bacillus subtilis-Cu or CuSO4 During Pregnancy and Lactation Periods. Biological Trace Element Research 2019; 191(2) doi: 10.1007/s12011-019-1638-5
|
| 79 |
Shan-Shan Jiang, Ying-Xuan Chen, Jing-Yuan Fang. Fusobacterium nucleatum: ecology, pathogenesis and clinical implications. Nature Reviews Microbiology 2026; 24(3) doi: 10.1038/s41579-025-01237-z
|
| 80 |
Bo-Jian Peng, Chuang-Yu Cao, Wei Li, Yong-Jian Zhou, Yuan Zhang, Yu-Qiang Nie, Yan-Wen Cao, Yu-Yuan Li. Diagnostic Performance of Intestinal Fusobacterium nucleatum in Colorectal Cancer. Chinese Medical Journal 2018; 131(11) doi: 10.4103/0366-6999.232814
|
| 81 |
Yumi Shimomura, Yutaka Sugi, Aiko Kume, Wataru Tanaka, Tsutomu Yoshihara, Tetsuya Matsuura, Yasuhiko Komiya, Yusuke Ogata, Wataru Suda, Masahira Hattori, Takuma Higurashi, Atsushi Nakajima, Mitsuharu Matsumoto, Olga Soutourina, Emma Allen-Vercoe.
Strain-level detection of
Fusobacterium nucleatum
in colorectal cancer specimens by targeting the CRISPR–Cas region
. Microbiology Spectrum 2023; 11(6) doi: 10.1128/spectrum.05123-22
|
| 82 |
Wen Wu, Fanying Guo, Changzheng Wang, Xiao Qu, Qinying Wang, Yongzhi Yang, Yannan Yang, Yanlei Ma. Biomimetic “Trojan Horse” nanoparticles with biotactic behavior toward tumor-associated bacteria for targeted therapy of colorectal cancer. Cell Biomaterials 2025; 1(6) doi: 10.1016/j.celbio.2025.100092
|
| 83 |
Ayaka ISHIHARA, Kaoru SHIMADA, Tomoharu SUZUKI, Noriko TAKAMURA, Katsushige TADA, Haruhiko ISHIOKA, Harumi GOMI. <i>Fusobacterium nucleatum </i>Bacteremia Presenting as Portal Vein Thrombosis. Kansenshogaku Zasshi 2019; 93(6) doi: 10.11150/kansenshogakuzasshi.93.768
|
| 84 |
Kavita Pandey, Shahid Umar. Microbiome in drug resistance to colon cancer. Current Opinion in Physiology 2021; 23 doi: 10.1016/j.cophys.2021.100472
|
| 85 |
Yanglong Chen, Ying Lu, Yuting Ke, Yanling Li. Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers. Medicine 2019; 98(39) doi: 10.1097/MD.0000000000017221
|
| 86 |
Roghayeh Nouri, Alka Hasani, Mohammad Asgharzadeh, Fatemeh Yeganeh Sefidan, Fatemeh Hemmati, Mohammad Ahangarzadeh Rezaee. Roles of Gut Microbiota in Colorectal Carcinogenesis Providing a
Perspective for Early Diagnosis and Treatment. Current Pharmaceutical Biotechnology 2022; 23(13) doi: 10.2174/1389201023666220307112413
|
| 87 |
Meredith A.J. Hullar, Orsalem J. Kahsai, Courtney Hill, Lisa Levy, Rachel C. Malen, Keith R. Curtis, Hamza Ammar, Arthur Sillah, Adriana M. Reedy, Johanna W. Lampe, Shuji Ogino, John D. Potter, Polly A. Newcomb, Amanda I. Phipps. Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors. Cancer Epidemiology, Biomarkers & Prevention 2025; 34(8) doi: 10.1158/1055-9965.EPI-24-1020
|
| 88 |
Weigen Wu, Yaobin Ouyang, Pan Zheng, Xinbo Xu, Cong He, Chuan Xie, Junbo Hong, Nonghua Lu, Yin Zhu, Nianshuang Li. Research trends on the relationship between gut microbiota and colorectal cancer: A bibliometric analysis. Frontiers in Cellular and Infection Microbiology 2023; 12 doi: 10.3389/fcimb.2022.1027448
|
| 89 |
Mehrdad Mohammadi, Hamed Mirzaei, Mitra Motallebi. The role of anaerobic bacteria in the development and prevention of colorectal cancer: A review study. Anaerobe 2022; 73 doi: 10.1016/j.anaerobe.2021.102501
|
| 90 |
Aonghus Lavelle, Colin Hill. Gut Microbiome in Health and Disease. Gastroenterology Clinics of North America 2019; 48(2) doi: 10.1016/j.gtc.2019.02.003
|
| 91 |
Yuanyuan Wang, Jiahe li, Chenchen Ma, Shuaiming Jiang, Congfa Li, Lin Zhang, Jiachao Zhang.
Lactiplantibacillus plantarum HNU082 inhibited the growth of Fusobacterium nucleatum and alleviated the inflammatory response introduced by F. nucleatum invasion. Food & Function 2021; 12(21) doi: 10.1039/D1FO01388B
|
| 92 |
Davide Zella, Robert C. Gallo. Viruses and Bacteria Associated with Cancer: An Overview. Viruses 2021; 13(6) doi: 10.3390/v13061039
|
| 93 |
Ilija Barukčić. <i>Fusobacterium nucleatum</i>—The Cause of Human Colorectal Cancer. Journal of Biosciences and Medicines 2018; 6(03) doi: 10.4236/jbm.2018.63004
|
| 94 |
Jawad Abed, Naseem Maalouf, Abigail L. Manson, Ashlee M. Earl, Lishay Parhi, Johanna E. M. Emgård, Michael Klutstein, Shay Tayeb, Gideon Almogy, Karine A. Atlan, Stella Chaushu, Eran Israeli, Ofer Mandelboim, Wendy S. Garrett, Gilad Bachrach. Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.00400
|
| 95 |
Francesca Benedetti, Sabrina Curreli, Davide Zella. Mycoplasmas–Host Interaction: Mechanisms of Inflammation and Association with Cellular Transformation. Microorganisms 2020; 8(9) doi: 10.3390/microorganisms8091351
|
| 96 |
Yen Lin Chu, Peter Georgeson, Mark Clendenning, Khalid Mahmood, Romy Walker, Julia Como, Sharelle Joseland, Susan G. Preston, Toni Rice, Brigid M. Lynch, Roger L. Milne, Melissa C. Southey, Graham G. Giles, Amanda I. Phipps, John L. Hopper, Aung K. Win, Christophe Rosty, Finlay A. Macrae, Ingrid Winship, Mark A. Jenkins, Daniel D. Buchanan, Jihoon E. Joo. Intratumoural pks Escherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndrome. eBioMedicine 2025; 114 doi: 10.1016/j.ebiom.2025.105661
|
| 97 |
Asma Rafique, Young-Sang Koh.
Association of Fusobacterium nucleatum in the Progression of Colorectal Cancer
. Journal of Bacteriology and Virology 2021; 51(2) doi: 10.4167/jbv.2021.51.2.39
|
| 98 |
Narjess Bostanghadiri, Shabnam Razavi, Aref Shariati, Malihe Talebi, Shiva Mirkalantari, Amirnader Emami Razavi, Davood Darban-Sarokhalil. Exploring the interplay between Fusobacterium nucleatum with the expression of microRNA, and inflammatory mediators in colorectal cancer. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1302719
|
| 99 |
Marina A Senchukova. Genetic heterogeneity of colorectal cancer and the microbiome. World Journal of Gastrointestinal Oncology 2023; 15(3): 443-463 doi: 10.4251/wjgo.v15.i3.443
|
| 100 |
Francesca Benedetti, Giovannino Silvestri, Frank Denaro, Giovanni Finesso, Rafael Contreras-Galindo, Arshi Munawwar, Sumiko Williams, Harry Davis, Joseph Bryant, Yin Wang, Enrico Radaelli, Chozha V. Rathinam, Robert C. Gallo, Davide Zella. Mycoplasma DnaK expression increases cancer development in vivo upon DNA damage. Proceedings of the National Academy of Sciences 2024; 121(10) doi: 10.1073/pnas.2320859121
|
| 101 |
Sara Aghili, Hussein Rahimi, Lotfollah Kamali Hakim, Shahryar Karami, Reza Sayyad Soufdoost, Asal Bagherzadeh Oskouei, Mostafa Alam, Ashkan Badkoobeh, Mohsen Golkar, Kamyar Abbasi, Artak Heboyan, Zahra Sadat Hosseini. Interactions Between Oral Microbiota and Cancers in the Aging Community: A Narrative Review. Cancer Control 2024; 31 doi: 10.1177/10732748241270553
|
| 102 |
Wei Zheng, Yuxin Wang, Haoyang Sun, Surina Bao, Shuai Ge, Chunshan Quan. The role of Fusobacterium nucleatum in macrophage M2 polarization and NF-κB pathway activation in colorectal cancer. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1549564
|
| 103 |
Robin Mjelle, Wenche Sjursen, Liv Thommesen, Pål Sætrom, Eva Hofsli. Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5330-0
|
| 104 |
Samira Tarashi, Seyed Davar Siadat, Sara Ahmadi Badi, Mohammadreza Zali, Roberto Biassoni, Mirco Ponzoni, Arfa Moshiri. Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?. Microorganisms 2019; 7(11) doi: 10.3390/microorganisms7110561
|
| 105 |
Russell G. Witt, Samuel H. Cass, Tiffaney Tran, Ashish Damania, Emelie E. Nelson, Elizabeth Sirmans, Elizabeth M. Burton, Manoj Chelvanambi, Sarah Johnson, Hussein A. Tawbi, Jeffrey E. Gershenwald, Michael A. Davies, Christine Spencer, Aditya Mishra, Matthew C. Wong, Nadim J. Ajami, Christine B. Peterson, Carrie R. Daniel, Jennifer A. Wargo, Jennifer L. McQuade, Kelly C. Nelson. Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma. JAMA Dermatology 2023; 159(10) doi: 10.1001/jamadermatol.2023.2955
|
| 106 |
Siyi Yu, Shuyi Wang, Bin Xiong, Chunwei Peng. Gut microbiota: key facilitator in metastasis of colorectal cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1270991
|
| 107 |
Tu Wang, Ya-Qin Xie, Guang-Xin Miao, Hai-peng Cui, Kai Liu, Ying Li, Ying Li, Juan Zhao. Urotensin receptor antagonist urantide improves atherosclerosis-related kidney injury by inhibiting JAK2/STAT3 signaling pathway in rats. Life Sciences 2020; 247 doi: 10.1016/j.lfs.2020.117421
|
| 108 |
Theresa Dregelies, Franziska Haumaier, William Sterlacci, Steffen Backert, Michael Vieth. Detection of Fusobacterium nucleatum in Patients with Colitis-Associated Colorectal Cancer. Current Microbiology 2023; 80(9) doi: 10.1007/s00284-023-03398-7
|
| 109 |
Aref Shariati, Shabnam Razavi, Ehsanollah Ghaznavi-Rad, Behnaz Jahanbin, Abolfazl Akbari, Samira Norzaee, Davood Darban-Sarokhalil. Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study. Infectious Agents and Cancer 2021; 16(1) doi: 10.1186/s13027-021-00381-4
|
| 110 |
Cécily Lucas, Nicolas Barnich, Hang Nguyen. Microbiota, Inflammation and Colorectal Cancer. International Journal of Molecular Sciences 2017; 18(6) doi: 10.3390/ijms18061310
|
| 111 |
Tsuyoshi Hamada, Jonathan A Nowak, Danny A Milner, Mingyang Song, Shuji Ogino. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome‐driven neoplasms. The Journal of Pathology 2019; 247(5) doi: 10.1002/path.5236
|
| 112 |
Marcela Alcântara Proença, Joice Matos Biselli, Maysa Succi, Fábio Eduardo Severino, Gustavo Noriz Berardinelli, Alaor Caetano, Rui Manuel Reis, David J Hughes, Ana Elizabete Silva. Relationship between <i>Fusobacterium nucleatum</i>, inflammatory mediators and microRNAs in colorectal carcinogenesis. World Journal of Gastroenterology 2018; 24(47): 5351-5365 doi: 10.3748/wjg.v24.i47.5351
|
| 113 |
Zhujiang Dai, Jingqiu Zhang, Qi Wu, Juan Chen, Jun Liu, Lu Wang, Chaowu Chen, Jiaming Xu, Hongpeng Zhang, Chunfeng Shi, Zhen Li, Huiwen Fang, Chaobiao Lin, Dong Tang, Daorong Wang. The role of microbiota in the development of colorectal cancer. International Journal of Cancer 2019; 145(8) doi: 10.1002/ijc.32017
|
| 114 |
Tsuyoshi Hamada, Xuehong Zhang, Kosuke Mima, Susan Bullman, Yasutaka Sukawa, Jonathan A. Nowak, Keisuke Kosumi, Yohei Masugi, Tyler S. Twombly, Yin Cao, Mingyang Song, Li Liu, Annacarolina da Silva, Yan Shi, Mancang Gu, Wanwan Li, Hideo Koh, Katsuhiko Nosho, Kentaro Inamura, NaNa Keum, Kana Wu, Jeffrey A. Meyerhardt, Aleksandar D. Kostic, Curtis Huttenhower, Wendy S. Garrett, Matthew Meyerson, Edward L. Giovannucci, Andrew T. Chan, Charles S. Fuchs, Reiko Nishihara, Marios Giannakis, Shuji Ogino.
Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status. Cancer Immunology Research 2018; 6(11) doi: 10.1158/2326-6066.CIR-18-0174
|
| 115 |
Nađa Nikolić, Ana Pucar, Uroš Tomić, Sanja Petrović, Đorđe Mihailović, Aleksandar Jovanović, Milena Radunović. Oral Microbiota and Carcinogenesis: Exploring the Systemic Impact of Oral Pathogens. Pathogens 2025; 14(12) doi: 10.3390/pathogens14121233
|
| 116 |
Melinda A. Engevik, Heather A. Danhof, Wenly Ruan, Amy C. Engevik, Alexandra L. Chang-Graham, Kristen A. Engevik, Zhongcheng Shi, Yanling Zhao, Colleen K. Brand, Evan S. Krystofiak, Susan Venable, Xinli Liu, Kendal D. Hirschi, Joseph M. Hyser, Jennifer K. Spinler, Robert A. Britton, James Versalovic.
Fusobacterium nucleatum
Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation
. mBio 2021; 12(2) doi: 10.1128/mBio.02706-20
|
| 117 |
Ishfaq Ahmed, Shahid Umar. Microbiome and Colorectal Cancer. Current Colorectal Cancer Reports 2018; 14(6) doi: 10.1007/s11888-018-0416-7
|
| 118 |
Paola Villar-Ortega, Manuela Expósito-Ruiz, Miguel Gutiérrez-Soto, Miguel Ruiz-Cabello Jiménez, José María Navarro-Marí, José Gutiérrez-Fernández. The association between Fusobacterium nucleatum and cancer colorectal: A systematic review and meta-analysis. Enfermedades infecciosas y microbiologia clinica (English ed.) 2022; 40(5) doi: 10.1016/j.eimce.2022.02.007
|
| 119 |
Shuji Ogino, Jonathan A Nowak, Tsuyoshi Hamada, Amanda I Phipps, Ulrike Peters, Danny A Milner Jr, Edward L Giovannucci, Reiko Nishihara, Marios Giannakis, Wendy S Garrett, Mingyang Song. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut 2018; 67(6) doi: 10.1136/gutjnl-2017-315537
|
| 120 |
Yean Leng Loke, Ming Tsuey Chew, Yun Fong Ngeow, Wendy Wan Dee Lim, Suat Cheng Peh. Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.603086
|
| 121 |
Paola Villar-Ortega, Manuela Expósito-Ruiz, Miguel Gutiérrez-Soto, Miguel Ruiz-Cabello Jiménez, José María Navarro-Marí, José Gutiérrez-Fernández. La asociación entre Fusobacterium nucleatum y el cáncer colorrectal: una revisión sistemática y metaanálisis. Enfermedades Infecciosas y Microbiología Clínica 2022; 40(5) doi: 10.1016/j.eimc.2021.01.005
|
| 122 |
Jie Tang, Guodong Dun, Jing Li, Qiaolin Xu, Tao Zhang, Yuanzhi Lan, Linghai Zeng, Huaxing Luo, Yuanyuan Xiang, Bin Tang, Dongzhu Zeng. Isolation ofFusobacterium nucleatumfrom human feces using immunomagnetic separation coupled with fastidious anaerobe agar. Journal of Applied Microbiology 2023; 134(2) doi: 10.1093/jambio/lxac058
|
| 123 |
Miyuki Toda, Ryoki Kobayashi, Tomoko Kurita-Ochiai, Tetsuro Kono, Arata Watanabe, Hidenobu Senpuku, Hiroyuki Okada. The Mechanism of Inflammation Caused by Oral Infection with <i>Fusobacterium nucleatum</i> in Periodontal Tissue. International Journal of Oral-Medical Sciences 2023; 21(3) doi: 10.5466/ijoms.21.112
|
| 124 |
J. M. Keane, S. A. Joyce, C. G. M. Gahan, N. P. Hyland, A. Houston. Symbiosis: Cellular, Molecular, Medical and Evolutionary Aspects. Results and Problems in Cell Differentiation 2020; 69 doi: 10.1007/978-3-030-51849-3_22
|
| 125 |
Jessica Queen, Zam Cing, Hana Minsky, Asmita Nandi, Taylor Southward, Jacqueline Ferri, Madison McMann, Thevambiga Iyadorai, Jamuna Vadivelu, April Roslani, Mun Fai Loke, Jane Wanyiri, James R. White, Julia L. Drewes, Cynthia L. Sears. Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer. npj Biofilms and Microbiomes 2025; 11(1) doi: 10.1038/s41522-025-00717-7
|
| 126 |
Courtney M. Hill, Rachel C. Malen, Adriana M. Reedy, Orsalem Kahsai, Keith Curtis, Ningxin Ma, Timothy W. Randolph, Jing Ma, Claire E. Thomas, Shuji Ogino, John D. Potter, Daniel D. Buchanan, Polly A. Newcomb, Meredith A. J. Hullar, Amanda I. Phipps. Associations of epidemiologic risk factors with Fusobacterium nucleatum and bacterial alpha diversity in the colorectal tumor-associated microbiota. Cancer Causes & Control 2026; 37(3) doi: 10.1007/s10552-026-02133-4
|
| 127 |
Jorge Galan-Ros, Verónica Ramos-Arenas, Pablo Conesa-Zamora. Predictive Values of Colon Microbiota in the Treatment Response to Colorectal Cancer. Pharmacogenomics 2020; 21(14) doi: 10.2217/pgs-2020-0044
|
| 128 |
Zahra Elahi, Aref Shariati, Narjess Bostanghadiri, Leila Dadgar-Zankbar, Shabnam Razavi, Samira Norzaee, Saba Vazirbani Arasi, Davood Darban-Sarokhalil. Association of Lactobacillus, Firmicutes, Bifidobacterium, Clostridium, and Enterococcus with colorectal cancer in Iranian patients. Heliyon 2023; 9(12) doi: 10.1016/j.heliyon.2023.e22602
|
| 129 |
Hisham Hussan, Steven K Clinton, Kristen Roberts, Michael T Bailey. <i>Fusobacterium</i>’s link to colorectal neoplasia sequenced: A systematic review and future insights. World Journal of Gastroenterology 2017; 23(48): 8626-8650 doi: 10.3748/wjg.v23.i48.8626
|
| 130 |
Melike Kurt, Zeki Yumuk. Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81171-1
|
| 131 |
Lelde Lauka, Elisa Reitano, Maria Clotilde Carra, Federica Gaiani, Paschalis Gavriilidis, Francesco Brunetti, Gian Luigi de’Angelis, Iradj Sobhani, Nicola de’Angelis. Role of the intestinal microbiome in colorectal cancer surgery outcomes. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1754-x
|
| 132 |
Ahmad Alzamami, Norah A. Alturki, Kanwal Khan, Zarrin Basharat, Mutaib M. Mashraqi. Screening inhibitors against the Ef-Tu of Fusobacterium nucleatum: a docking, ADMET and PBPK assessment study. Molecular Diversity 2024; 28(6) doi: 10.1007/s11030-024-10815-x
|
| 133 |
Zhen Li, Chao Shi, Jiawen Zheng, Yongjun Guo, Taibing Fan, Huan Zhao, Dongdong Jian, Xiaolei Cheng, Hao Tang, Jie Ma. Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma. BMC Microbiology 2021; 21(1) doi: 10.1186/s12866-021-02352-6
|
| 134 |
Natsumi Fujiwara, Naoya Kitamura, Kaya Yoshida, Tetsuya Yamamoto, Kazumi Ozaki, Yasusei Kudo. Involvement of Fusobacterium Species in Oral Cancer Progression: A Literature Review Including Other Types of Cancer. International Journal of Molecular Sciences 2020; 21(17) doi: 10.3390/ijms21176207
|
| 135 |
Charlotte Henstra, Jasper van Praagh, Peter Olinga, Anika Nagelkerke. The gastrointestinal microbiota in colorectal cancer cell migration and invasion. Clinical & Experimental Metastasis 2021; 38(6) doi: 10.1007/s10585-021-10130-x
|
| 136 |
José Guilherme Datorre, Ana Carolina de Carvalho, Denise Peixoto Guimarães, Rui Manuel Reis. The Role of <b><i>Fusobacterium nucleatum</i></b> in Colorectal Carcinogenesis. Pathobiology 2021; 88(2) doi: 10.1159/000512175
|
| 137 |
Marie S. Rye, Kerryn L. Garrett, Robert A. Holt, Cameron F. Platell, Melanie J. McCoy, Jonathan Jacobs. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load. PLOS ONE 2022; 17(1) doi: 10.1371/journal.pone.0262416
|
| 138 |
Tsuyoshi Hamada, NaNa Keum, Reiko Nishihara, Shuji Ogino. Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. Journal of Gastroenterology 2017; 52(3) doi: 10.1007/s00535-016-1272-3
|
| 139 |
Implication of gut microbes and its metabolites in colorectal cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(1) doi: 10.1007/s00432-022-04422-2
|
| 140 |
James L Gutmann, Vivian Manjarrés, Catalina Mendez De La Espriella. An inciteful perspective on bacterial species involved in the persistence of apical periodontitis. Endodontology 2021; 33(4) doi: 10.4103/endo.endo_214_21
|
| 141 |
Siew-Wai Pang, Subasri Armon, Jack Bee Chook, Jactty Chew, Kaik-Boo Peh, Wendy Wan-Dee Lim, Suat Cheng Peh, Sin-Yeang Teow. Association of Fusobacterium nucleatum infection with the clinicopathological characteristics in colorectal cancer patients. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-023-09150-5
|
| 142 |
Anjali Chander, Huile Lim, Gilad Bachrach, Miguel Reis Ferreira. The Dual Face of Fusobacterium nucleatum in Cancer: Foe, Friend or Both?. Journal of Periodontal Research 2026; doi: 10.1111/jre.70165
|
| 143 |
Shashanka K. Prasad, Smitha Bhat, Dharini Shashank, Akshatha C. R., Sindhu R., Pornchai Rachtanapun, Devananda Devegowda, Prasanna K. Santhekadur, Sarana Rose Sommano. Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.836004
|
| 144 |
Emilie Palmgren Colov, Thea Helene Degett, Hans Raskov, Ismail Gögenur. The impact of the gut microbiota on prognosis after surgery for colorectal cancer – a systematic review and meta‐analysis. APMIS 2020; 128(2) doi: 10.1111/apm.13032
|
| 145 |
Julia L. Drewes, James R. White, Christine M. Dejea, Payam Fathi, Thevambiga Iyadorai, Jamuna Vadivelu, April C. Roslani, Elizabeth C. Wick, Emmanuel F. Mongodin, Mun Fai Loke, Kumar Thulasi, Han Ming Gan, Khean Lee Goh, Hoong Yin Chong, Sandip Kumar, Jane W. Wanyiri, Cynthia L. Sears. High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia. npj Biofilms and Microbiomes 2017; 3(1) doi: 10.1038/s41522-017-0040-3
|
| 146 |
Yixin Chen, Chenglin Yu, Jiannan Chai, Min Chai, Yuqi Xiao, Hongwei Loong, Dahai Xu, Lijun Wang. Fusobacterium nucleatum-Induced Pyopneumothorax: A Rare but Serious Clinical Entity. Infection and Drug Resistance 2025; doi: 10.2147/IDR.S530213
|
| 147 |
Ni Wang, Jing-Yuan Fang. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer. Trends in Microbiology 2023; 31(2) doi: 10.1016/j.tim.2022.08.010
|
| 148 |
Yi Wang, Yuting Wen, Jiayin Wang, Xin Lai, Ying Xu, Xuanping Zhang, Xiaoyan Zhu, Chenglin Ruan, Yao Huang. Clinicopathological differences of high Fusobacterium nucleatum levels in colorectal cancer: A review and meta-analysis. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.945463
|
| 149 |
Jessica Queen, Jada C. Domingue, James Robert White, Courtney Stevens, Barath Udayasuryan, Tam T. D. Nguyen, Shaoguang Wu, Hua Ding, Hongni Fan, Madison McMann, Alina Corona, Tatianna C. Larman, Scott S. Verbridge, Franck Housseau, Daniel J. Slade, Julia L. Drewes, Cynthia L. Sears, Claire M. Fraser. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models. mBio 2022; 13(1) doi: 10.1128/mbio.02991-21
|
| 150 |
Roseanna C. Wheatley, Elaine Kilgour, Timothy Jacobs, Angela Lamarca, Richard A. Hubner, Juan W. Valle, Mairéad G. McNamara. Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy. British Journal of Cancer 2022; 126(5) doi: 10.1038/s41416-021-01583-8
|
| 151 |
Sherri Huang, Diptaraj S. Chaudhari, Rohit Shukla, Pushti Kanani, Rola S. Zeidan, Yi Lin, Wesley Burrow, Robert T. Mankowski, Shalini Jain, Hariom Yadav. Global Microbiome: Core and Unique Signatures Across Diverse Populations. International Journal of Molecular Sciences 2026; 27(4) doi: 10.3390/ijms27041776
|
| 152 |
Seul A. Lee, Fang Liu, Stephen M. Riordan, Cheok S. Lee, Li Zhang. Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00566
|
| 153 |
Zhenhua Yang, Guang Ji. Fusobacterium�nucleatum‑positive colorectal cancer (Review). Oncology Letters 2019; doi: 10.3892/ol.2019.10433
|
| 154 |
Suwen Ou, Hufei Wang, Yangbao Tao, Kangjia Luo, Jinhua Ye, Songlin Ran, Zilong Guan, Yuliuming Wang, Hanqing Hu, Rui Huang. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.1020583
|
| 155 |
Sunjae Lee, Theo Portlock, Emmanuelle Le Chatelier, Fernando Garcia-Guevara, Frederick Clasen, Florian Plaza Oñate, Nicolas Pons, Neelu Begum, Azadeh Harzandi, Ceri Proffitt, Dorines Rosario, Stefania Vaga, Junseok Park, Kalle von Feilitzen, Fredric Johansson, Cheng Zhang, Lindsey A. Edwards, Vincent Lombard, Franck Gauthier, Claire J. Steves, David Gomez-Cabrero, Bernard Henrissat, Doheon Lee, Lars Engstrand, Debbie L. Shawcross, Gordon Proctor, Mathieu Almeida, Jens Nielsen, Adil Mardinoglu, David L. Moyes, Stanislav Dusko Ehrlich, Mathias Uhlen, Saeed Shoaie. Global compositional and functional states of the human gut microbiome in health and disease. Genome Research 2024; 34(6) doi: 10.1101/gr.278637.123
|
| 156 |
Sui Wan, Gang Huang, Jue-Xin Wang, Lin Tian, Xiu-Li Zuo, Qing-Yan Li, Yan-Bo Yu. Altered Gut Microbiota in Patients With Peutz-Jeghers Syndrome. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4022526
|
| 157 |
Shanru He, Yuanyuan Chen, Lulu Wang, Xue Bai, Tingting Bu, Jie Zhang, Ming Lu, Nam-Chul Ha, Chunshan Quan, Ki Hyun Nam, Yongbin Xu. Structural and Functional Analysis of the Pyridoxal Phosphate Homeostasis Protein YggS from Fusobacterium nucleatum. Molecules 2022; 27(15) doi: 10.3390/molecules27154781
|
| 158 |
Ronald Heregger, Florian Huemer, Richard Greil, Marina Canadas-Ortega, Gernot Posselt, Marieke E Ijsselsteijn, Christina Plattner, Dietmar Rieder, Zlatko Trajanoski, Anne Krogsdam, Eckhard Klieser, Daniel Neureiter, Silja Wessler, Lukas Weiss. Impact of Fusobacterium nucleatum on immune cell interactions and gene expression in colorectal cancer: a retrospective cohort study. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1629014
|
| 159 |
Haytam Mahmoudy, Imane Guemih, Moulay Mustapha Ennaji. Cancer Biomarkers and Oncoviruses. 2026; doi: 10.1016/B978-0-443-30225-1.00039-7
|
| 160 |
Sui Wang, Gang Huang, Jue-Xin Wang, Lin Tian, Xiu-Li Zuo, Yan-Qing Li, Yan-Bo Yu. Altered Gut Microbiota in Patients With Peutz–Jeghers Syndrome. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.881508
|
| 161 |
Wantong Song, Karthik Tiruthani, Ying Wang, Limei Shen, Mengying Hu, Oleksandra Dorosheva, Kunyu Qiu, Karina A. Kinghorn, Rihe Liu, Leaf Huang. Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis. Advanced Materials 2018; 30(52) doi: 10.1002/adma.201805007
|